PaxMedica, Inc. (PXMD) has released an update to notify the public and investors about its officers.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PaxMedica, Inc.’s Board approved the acceleration of vesting for certain restricted stock units (RSUs) to lessen administrative burdens. Key executives, including President and CEO Howard Weisman, CFO and COO Stephen Sheldon, and Chief Medical Officer Dr. David Hough, will benefit from this acceleration. The accelerated RSUs, whose values are based on the company’s closing stock price, will fully vest the day after the annual report is filed, contingent upon continued employment.
For further insights into PXMD corporate activity, check out TipRanks’ Insiders Trading Activity page.